US IPO Weekly Winners & Losers
RenaissanceCapital·- The US IPO market experienced a slowdown due to a valuation mismatch between buyers and sellers, leading to recent postponements. - Biotech firm ADARx Pharmaceuticals raised 446 million dollars and returned plus 13.8 percent, while upcoming listings include Oura and Accelevation. - The Renaissance IPO Index gained plus 2.2 percent last week, outperforming the S&P 500's plus 1.2 percent despite broader market challenges.